Data / Form D filings / Ocean Biomedical, Inc.
Ocean Biomedical, Inc.: Form D filing
Ocean Biomedical, Inc., a biotechnology company in Providence, RI, filed a Form D with the SEC in 2021. The latest, on April 12, 2021, reports $1 million sold of an offering with no set size to 27 investors.
Find out what Ocean Biomedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 55 CLAVERICK STREET, ROOM 325, Providence, RI, 02903
- Phone
- (401) 444-7375
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1836612
The full lists. Form D filings in Rhode Island: 60 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 12, 2021 | New notice | Indefinite | $1,044,657 | Indefinite | 27 | Mar 22, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chirinjeev Kathuria, | Executive Officer, Director | |
| Elizabeth Ng | Executive Officer, Director | |
| Jonathan Heller | Executive Officer | |
| Gurinder Kalra | Executive Officer |
Every Form D from the week of Apr 12, 2021 · All recent filings in Rhode Island · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ocean Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.